Home Cart Sign in  
Chemical Structure| 2070014-94-5 Chemical Structure| 2070014-94-5

Structure of SR9011 HCl
CAS No.: 2070014-94-5

Chemical Structure| 2070014-94-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

SR9011 is the agonist for REV-ERB-α with IC50 of 670 nM and REV-ERB-β with IC50 of 800 nM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of SR9011 HCl

CAS No. :2070014-94-5
Formula : C23H32Cl2N4O3S
M.W : 515.50
SMILES Code : O=C(N1CC(CN(CC2=CC=C(Cl)C=C2)CC3=CC=C([N+]([O-])=O)S3)CC1)NCCCCC.[H]Cl
MDL No. :N/A

Safety of SR9011 HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Melanoma cells 20µM 72 hours SR9011 induces apoptosis in melanoma cells Nature. 2018 Jan 18;553(7688):351-355.
Breast cancer cells 20µM 72 hours SR9011 induces apoptosis in breast cancer cells Nature. 2018 Jan 18;553(7688):351-355.
Acute T cell leukemia cells 20µM 72 hours SR9011 shows significant cytotoxicity to acute T cell leukemia cells Nature. 2018 Jan 18;553(7688):351-355.
BV2 cells 0–10μM 4 hours SR9011 inhibited LPS-induced iNOS and COX-2 protein expression Acta Pharmacol Sin. 2019 Jan;40(1):26-34.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice GBM mouse model Intraperitoneal injection 100 mg/kg Once daily for 10 days To evaluate the effect of SR9009 on tumor angiogenesis Cell Rep. 2023 Feb 28;42(2):112127.
Mice C57BL/6 mice Intraperitoneal injection 100 mg/kg SR9011 Every 3 days for 24 hours To study the effect of Rev-erb α activation on EPO production under hypoxic conditions, results showed that SR9011 significantly reduced DMOG-induced EPO mRNA levels Blood Adv. 2024 Jul 23;8(14):3705-3717.
Mice C57BL6 and Balb/c male mice Intraperitoneal injection 100 mg/kg Twice daily for 3 to 10 days Evaluate the effects of SR9011 on sleep and anxiety behavior Nat Commun. 2014 Dec 23;5:5759
Mice C57BL6 and Balb/c mice Intraperitoneal injection 100 mg/kg Twice per day for 10-12 days Evaluate the effects of SR9011 and SR9009 on circadian behavior and metabolism Nature. 2012 Mar 29;485(7396):62-8
Mice OVA-induced asthma model Intraperitoneal injection 100 mg/kg Once daily until the final challenge day (day 24) Evaluate the alleviating effect of SR9011 on asthma severity, results showed SR9011 eased disease severity by suppressing Th2 responses Cell Mol Life Sci. 2022 May 21;79(6):308

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.94mL

0.39mL

0.19mL

9.70mL

1.94mL

0.97mL

19.40mL

3.88mL

1.94mL

References

 

Historical Records

Categories